CoChat

NMDA 2A receptors in parvalbumin cells mediate sex-specific rapid ketamine response on cortical activity

Open access
Picard, Nathalie, Takesian, Anne E., Fagiolini, Michela, Hensch, Takao K. · 2019 · Molecular Psychiatry

The DOI matches its Crossref record; 77 of the 77 references it cites were found in a registry or an index.

Abstract

Ketamine has emerged as a widespread treatment for a variety of psychiatric disorders when used at sub-anesthetic doses, but the neural mechanisms underlying its acute action remain unclear. Here, we identified NMDA receptors containing the 2A subunit (GluN2A) on parvalbumin (PV)-expressing inhibitory interneurons as a pivotal target of low-dose ketamine. Genetically deleting GluN2A receptors globally or selectively from PV interneurons abolished the rapid enhancement of visual cortical responses and gamma-band oscillations by ketamine. Moreover, during the follicular phase of the estrous cycle in female mice, the ketamine response was transiently attenuated along with a concomitant decrease of grin2A mRNA expression within PV interneurons. Thus, GluN2A receptors on PV interneurons mediate the immediate actions of low-dose ketamine treatment, and fluctuations in receptor expression across the estrous cycle may underlie sex-differences in drug efficacy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41380-018-0341-9

Cites

77 of 77 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 GluN2A receptors mediate the rapid actions of low-dose ketamine. a Evoked responses from primary visual cortex in vivo using a multisite silicon probe through the depth of cortex. Pyramidal-cell activity was recorded in response to drifting gratings of different orientation (30° spacing; 3–10 repeats) to determine the maximal evoked response for each cell. b Pyramidal-cell activity was recorded before/after one injection of low-dose ketamine (8 mg/kg, i.p.). Rapid changes in activity were evaluated over 30 min post-injection (top). Representative example of cell activity before and after 30 min of ketamine in wildtype controls (WT; bottom). c Ketamine-induced changes of maximal evoked response in WT (black filled square, n = 171 cells; 13 males) and GluN2A−/− mice (blue filled circle, n = 54 cells; 6 males) (median ± 95% CI. Asterisk refers to Friedman test with Dunn’s multiple comparison vs baseline. Hash refers to Kruskal–Wallis with Dunn’s multiple comparison WT vs GluN2A−/− mice). d Spectrogram comparison from WT at baseline (black trace) and 30 min post-ketamine (purple trace). Solid lines, mean of all mice; shaded areas, sem. Spectrogram calculated as a percentage of total power measured between 4 and 100 Hz (n = 10 mice). p-Value of two-way RM ANOVA: yellow shading, regions with statistically significant effect (Sidak’s multiple comparison p < 0.05). Inset, quantification of γ-oscillations between 20–50 Hz and 25–35 Hz (asterisk refers to Wilcoxon paired test baseline vs 30 min). e Spectrogram comparison from GluN2A−/− mice at baseline and 30 min post-ketamine (n = 6 mice). Inset, quantification of γ-oscillations between 20–50 Hz and 25–35 Hz
Fig. 1 GluN2A receptors mediate the rapid actions of low-dose ketamine. a Evoked responses from primary visual cortex in vivo using a multisite silicon probe through the depth of cortex. Pyramidal-cell activity was recorded in response to drifting gratings of different orientation (30° spacing; 3–10 repeats) to determine the maximal evoked response for each cell. b Pyramidal-cell activity was recorded before/after one injection of low-dose ketamine (8 mg/kg, i.p.). Rapid changes in activity were evaluated over 30 min post-injection (top). Representative example of cell activity before and after 30 min of ketamine in wildtype controls (WT; bottom). c Ketamine-induced changes of maximal evoked response in WT (black filled square, n = 171 cells; 13 males) and GluN2A−/− mice (blue filled circle, n = 54 cells; 6 males) (median ± 95% CI. Asterisk refers to Friedman test with Dunn’s multiple comparison vs baseline. Hash refers to Kruskal–Wallis with Dunn’s multiple comparison WT vs GluN2A−/− mice). d Spectrogram comparison from WT at baseline (black trace) and 30 min post-ketamine (purple trace). Solid lines, mean of all mice; shaded areas, sem. Spectrogram calculated as a percentage of total power measured between 4 and 100 Hz (n = 10 mice). p-Value of two-way RM ANOVA: yellow shading, regions with statistically significant effect (Sidak’s multiple comparison p < 0.05). Inset, quantification of γ-oscillations between 20–50 Hz and 25–35 Hz (asterisk refers to Wilcoxon paired test baseline vs 30 min). e Spectrogram comparison from GluN2A−/− mice at baseline and 30 min post-ketamine (n = 6 mice). Inset, quantification of γ-oscillations between 20–50 Hz and 25–35 HzCC BY · PubMed Central
Fig. 2 Rapid ketamine action in fast-spiking PV-cells. a Representative raster plots of fast-spiking cells in V1 recorded in vivo at baseline and 5 min post-ketamine injection (top). Firing rate changes in these putative inhibitory cells recorded in response to visual gratings (n = 17, Wilcoxon matched paired test, p = 0.038) (bottom). b Representative NMDA receptor-mediated excitatory post-synaptic currents (EPSCNMDA) recorded from PV-cells in vitro in WT males at baseline (black traces), 15 min after bath application of ketamine (10 µM, purple line) then CPP/AP5 (gray trace). c Quantification of EPSCNMDA amplitude normalized to baseline (mean ± sem, n = 9 cells, 6 mice; matched paired test, F = 5.85, p = 0.042). d Representative in situ hybridization images from WT mice depicting co-localization of grin2A and interneuron marker (Pvalb) in visual cortex. e Integrated density (IntDen) of Pvalb and grin2A in PV-positive cells (median ± 95% CI, n = 62 cells). f Positive correlation between Pvalb and grin2A expression (Spearman p = 0.0005)
Fig. 2 Rapid ketamine action in fast-spiking PV-cells. a Representative raster plots of fast-spiking cells in V1 recorded in vivo at baseline and 5 min post-ketamine injection (top). Firing rate changes in these putative inhibitory cells recorded in response to visual gratings (n = 17, Wilcoxon matched paired test, p = 0.038) (bottom). b Representative NMDA receptor-mediated excitatory post-synaptic currents (EPSCNMDA) recorded from PV-cells in vitro in WT males at baseline (black traces), 15 min after bath application of ketamine (10 µM, purple line) then CPP/AP5 (gray trace). c Quantification of EPSCNMDA amplitude normalized to baseline (mean ± sem, n = 9 cells, 6 mice; matched paired test, F = 5.85, p = 0.042). d Representative in situ hybridization images from WT mice depicting co-localization of grin2A and interneuron marker (Pvalb) in visual cortex. e Integrated density (IntDen) of Pvalb and grin2A in PV-positive cells (median ± 95% CI, n = 62 cells). f Positive correlation between Pvalb and grin2A expression (Spearman p = 0.0005)CC BY · PubMed Central
Fig. 3 GluN2A receptors on PV-cells mediate rapid ketamine action. a Schematic of PV-Cre+/GluN2Af/f mouse construction. b Ketamine-induced changes of maximal evoked response were abolished in PV-Cre+/GluN2Af/f males (blue filled circle, n = 72, 6 mice) (% of pre-ketamine level, median ± 95% CI; asterisk refers to Friedman test with Dunn’s multiple comparison vs baseline; hash refers to Kruskal–Wallis with Dunn’s multiple comparison WT vs mutant). c Spectrogram comparison from WT at baseline (black trace) and 30 min post-ketamine (purple trace). Solid lines, mean of all mice; shaded areas, sem. Spectrogram calculated as a percentage of total power measured between 4 and 100 Hz (n = 6 mice). p-Value of two-way row matched ANOVA. Inset, quantification of γ-oscillations between 20–50 Hz and 25–35 Hz
Fig. 3 GluN2A receptors on PV-cells mediate rapid ketamine action. a Schematic of PV-Cre+/GluN2Af/f mouse construction. b Ketamine-induced changes of maximal evoked response were abolished in PV-Cre+/GluN2Af/f males (blue filled circle, n = 72, 6 mice) (% of pre-ketamine level, median ± 95% CI; asterisk refers to Friedman test with Dunn’s multiple comparison vs baseline; hash refers to Kruskal–Wallis with Dunn’s multiple comparison WT vs mutant). c Spectrogram comparison from WT at baseline (black trace) and 30 min post-ketamine (purple trace). Solid lines, mean of all mice; shaded areas, sem. Spectrogram calculated as a percentage of total power measured between 4 and 100 Hz (n = 6 mice). p-Value of two-way row matched ANOVA. Inset, quantification of γ-oscillations between 20–50 Hz and 25–35 HzCC BY · PubMed Central
Fig. 4 Attenuated female response to ketamine during the follicular phase. a Representative vaginal smears during Estrus, Metestrus, Diestrus, and Proestrus stages of the estrous cycle. b Ketamine-induced changes of maximal evoked response in C57Bl/6J females during the follicular phase (Estrus/Proestrus, red filled circles, n = 87 cells; 5 mice) and luteal phase (Metestrus/Diestrus, gray circles, n = 82 cells; 6 mice) (median ± 95% CI; asterisk refers to Friedman test with Dunn’s multiple comparison vs baseline; hash refers to Kruskal–Wallis with Dunn’s multiple comparison follicular vs luteal). Dotted line, C57Bl/6J male values for comparison (n = 67 cells/4 mice). c Representative in situ hybridization images of female mouse V1 showing different categories of Pvalb-positive cells. d Integrated density of Pvalb mRNA in luteal and follicular stages (median ± 95% CI, n = 81 and 90 cells; Kruskal–Wallis test, not significant). e Integrated density (IntDen) of grin2A mRNA in luteal and follicular stages (Mann–Whitney, p = 0.0016). Dotted line, median value in males. f Proportion of Pvalb-positive cells without grin2A (0), low level (L: IntDen < 15% percentiles in males), medium (M) or high level of grin2A expression (H: IntDen > 85% percentiles in males). Males (black) and females during luteal (gray) and follicular (red) phases (asterisk refers to χ2-test). g Positive correlation between Pvalb and grin2A expression in females
Fig. 4 Attenuated female response to ketamine during the follicular phase. a Representative vaginal smears during Estrus, Metestrus, Diestrus, and Proestrus stages of the estrous cycle. b Ketamine-induced changes of maximal evoked response in C57Bl/6J females during the follicular phase (Estrus/Proestrus, red filled circles, n = 87 cells; 5 mice) and luteal phase (Metestrus/Diestrus, gray circles, n = 82 cells; 6 mice) (median ± 95% CI; asterisk refers to Friedman test with Dunn’s multiple comparison vs baseline; hash refers to Kruskal–Wallis with Dunn’s multiple comparison follicular vs luteal). Dotted line, C57Bl/6J male values for comparison (n = 67 cells/4 mice). c Representative in situ hybridization images of female mouse V1 showing different categories of Pvalb-positive cells. d Integrated density of Pvalb mRNA in luteal and follicular stages (median ± 95% CI, n = 81 and 90 cells; Kruskal–Wallis test, not significant). e Integrated density (IntDen) of grin2A mRNA in luteal and follicular stages (Mann–Whitney, p = 0.0016). Dotted line, median value in males. f Proportion of Pvalb-positive cells without grin2A (0), low level (L: IntDen < 15% percentiles in males), medium (M) or high level of grin2A expression (H: IntDen > 85% percentiles in males). Males (black) and females during luteal (gray) and follicular (red) phases (asterisk refers to χ2-test). g Positive correlation between Pvalb and grin2A expression in femalesCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 77 references

Cited by

See all 77

Metadata

Authors
Picard, N., Takesian, A. E., Fagiolini, M., & Hensch, T. K.
Affiliations
Boston Children's Hospital (US)
Corresponding author
  • Fagiolini, Michela
  • Hensch, Takao K.
Venue
Molecular Psychiatry
Published
2019-01-29
Volume
24
Issue
6
Pages
828-838
ISSN
  • 1359-4184 (ISSN-L)
  • 1476-5578
OpenAlex
W2911866952
Cited by
71
References
77
Citations by year
2026: 14 · 2025: 7 · 2024: 7 · 2023: 7 · 2022: 6 · 2021: 13 · 2020: 14 · 2019: 3
FWCI
5.58
Type
journal article
Language
en
Open access
Licence
Locations
  • Molecular Psychiatry (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (1P50MH094271)
  • Pfizer
  • Nancy Lurie Marks Family Foundation
  • U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (R01 NS095959)
  • U.S. Department of Health & Human Services | NIH | National Eye Institute (R01 EY013613)
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
Keywords
NMDA receptor, GluN2A, parvalbumin interneurons, ketamine, sex differences, estrous cycle, gamma oscillations, visual cortex, cortical responses, GRIN2A, inhibitory interneurons, low-dose ketamine
MeSH terms
Animals, Female, Interneurons, Ketamine, Male, Mice, Inbred C57BL, Parvalbumins, Receptors, GABA-A, Sex Factors, Receptors, N-Methyl-D-Aspartate, N-Methylaspartate, Prefrontal Cortex, Estrous Cycle, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: NMDA 2A receptors in parvalbumin cells mediate sex-specific rapid ketamine response on cortical activity. https://app.cochat.ai/papers/10.1038/s41380-018-0341-9
The paper
Picard, N., Takesian, A. E., Fagiolini, M., & Hensch, T. K. (2019). NMDA 2A receptors in parvalbumin cells mediate sex-specific rapid ketamine response on cortical activity. Molecular Psychiatry. https://doi.org/10.1038/s41380-018-0341-9

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.